Medical Equipment

Global Enzyme Immunoassay Market Revenue Expected To Reach $30.37 Billion By 2030

May 12, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Is The Estimated Growth In Market Size Of The Enzyme Immunoassay Market During 2026–2030?

The enzyme immunoassay market size has demonstrated robust growth in recent years. It is projected to increase from $21.5 billion in 2025 to $23.09 billion in 2026, at a compound annual growth rate (CAGR) of 7.4%. This historical expansion can be attributed to several factors including limited availability of automated eia systems, reliance on manual microplate readers, growing clinical laboratory infrastructure, increasing prevalence of chronic and infectious diseases, and the adoption of conventional reagents and kits.

The enzyme immunoassay market is projected to experience substantial expansion over the coming years. By 2030, this market is anticipated to reach a valuation of $30.37 billion, achieving a compound annual growth rate (CAGR) of 7.1%. This projected growth during the forecast period can be primarily attributed to several factors, including the advancement of fully automated EIA analyzers, the broadening scope of personalized medicine and precision diagnostics, the greater integration of laboratory information systems, an increase in the adoption of software and data analysis tools, and the increasing demand originating from academic and research institutions. Key trends expected within this period encompass the growing embrace of automated EIA analyzers, a surge in therapeutic drug monitoring applications, the expanding utilization of multiplex testing and high-throughput assays, the widened application in oncology and infectious disease testing, and an intensified emphasis on laboratory data integration and workflow efficiency.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25763&type=smp

What Are The Main Drivers Accelerating The Growth Of The Enzyme Immunoassay Market?

The expanding prevalence of infectious diseases is anticipated to drive the advancement of the enzyme immunoassay market in the future. These diseases are ailments resulting from detrimental microorganisms like bacteria, viruses, fungi, or parasites, which can transmit between individuals. The weight of infectious diseases is increasing because antimicrobial resistance complicates the treatment of everyday infections, leading to longer illnesses, elevated healthcare expenses, and a rise in fatalities. Enzyme immunoassays prove extremely beneficial in diagnosing infectious conditions, facilitating the precise and sensitive identification of antigens or antibodies within patient specimens. This capability supports prompt detection, efficient tracking, and opportune therapy for infections including HIV, hepatitis, and influenza. As an illustration, the Minnesota Department of Health, a US government body, reported in April 2025 that the proportion of HIV diagnoses among males between 35 to 39 years old climbed from 10% in 2023 to 17% in 2024, showing a significant rise in the percentage of total cases within this demographic. Consequently, the increasing incidence of infectious diseases is fueling the expansion of the enzyme immunoassay market.

How Does Segment Analysis Break Down The Enzyme Immunoassay Market Structure?

The enzyme immunoassay market covered in this report is segmented –

1) By Product: Reagents And Kits, Analyzers Or Instruments, Software And Services

2) By Specimen: Blood, Saliva, Urine, Other Specimens

3) By Application: Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications

4) By End-Use: Hospitals, Blood Banks, Clinical Laboratories, Pharmaceutical And Biotech Companies, Academic Research Centers, Other End-Uses

Subsegments:

1) By Reagents And Kits: Antibodies, Antigens, Substrates, Buffers And Stabilizers

2) By Analyzers Or Instruments: Fully Automated EIA Analyzers, Semi-Automated EIA Systems, Microplate Readers, Washers And Incubators

3) By Software And Services: Data Analysis And Interpretation Software, Laboratory Information System Integration Tools, Instrument Calibration And Validation Services, Technical Support And User Training

What Trends Are Shaping The Enzyme Immunoassay Market Structure?

Key players in the enzyme immunoassay market are prioritizing the launch of inventive enzyme immunoassay (EIA) solutions, including fully automated enzyme immunoassays, to elevate diagnostic precision, diminish manual errors, and enhance the efficiency of laboratory workflows in clinical settings. Fully automated enzyme immunoassays refer to diagnostic systems that execute the complete testing procedure automatically, thereby boosting the speed, accuracy, and reliability of laboratory results. For example, in July 2024, Fujirebio Holdings Inc., a Japan-based in vitro diagnostics (IVD) company, introduced the fully automated Lumipulse G GFAP assay for research use only (RUO), thereby expanding its portfolio of neuro-biomarkers. This RUO chemiluminescent enzyme immunoassay measures glial fibrillary acidic protein (GFAP) in human plasma and serum using the LUMIPULSE G platform, delivering results in a mere 35 minutes. It serves as an astrocytic biomarker associated with conditions such as multiple sclerosis, Alzheimer’s and Parkinson’s diseases, stroke, and traumatic brain injury. This assay further enhances Fujirebio’s expanding neuro menu, which already encompasses NfL, pTau217, and sTREM2, enabling comprehensive neurodegenerative disease profiling on a single automated system.

Which Industry Players Are Present In The Enzyme Immunoassay Market?

Major companies operating in the enzyme immunoassay market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Danaher Corporation, Merck KGaA, Siemens Healthineers AG, Becton Dickinson and Company (BD), PerkinElmer Inc., BioMérieux SA, Bio-Rad Laboratories Inc., Diasorin S.p.A., Bio-Techne Corporation, Quidel Corporation, Promega Corporation, Abcam plc, BioLegend Inc., Helena Laboratories Corporation, Cayman Chemical Company, Enzo Life Sciences Inc., RayBiotech Inc., MyBioSource Inc., Boster Biological Technology, Hycult Biotech, Calbiotech Inc.

Access The Complete Enzyme Immunoassay Market Report:

https://www.thebusinessresearchcompany.com/report/enzyme-immunoassay-global-market-report

Which Region Commands The Largest Share Of The Enzyme Immunoassay Market?

North America was the largest region in the enzyme immunoassay market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the enzyme immunoassay market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Enzyme Immunoassay Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=25763&type=smp

Browse Through More Reports Similar to the Global Enzyme Immunoassay Market 2026, By The Business Research Company

Enteral Feeding Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/enteral-feeding-devices-global-market-report

Enteral Feeding Formula Market Report 2026

https://www.thebusinessresearchcompany.com/report/enteral-feeding-formula-global-market-report

Enteral Nutrition Market Report 2026

https://www.thebusinessresearchcompany.com/report/enteral-nutrition-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795